Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A
Gespeichert in:
| Veröffentlicht in: | Haemophilia : the official journal of the World Federation of Hemophilia 2017-01, Vol.23 (1), p.e43-e46 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e46 |
|---|---|
| container_issue | 1 |
| container_start_page | e43 |
| container_title | Haemophilia : the official journal of the World Federation of Hemophilia |
| container_volume | 23 |
| creator | Ragni, M. V. Yabes, J. G. Fogarty, P. F. Josephson, N. C. Kessler, C. M. Neff, A. T. Raffini, L. Brummel‐Ziedins, K. Moore, C. G. |
| description | |
| doi_str_mv | 10.1111/hae.13131 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1852662132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1852662132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3881-5450dedd64820bd058aac1722b41e45461dd7628473a92e039fa49eaa72f57aa3</originalsourceid><addsrcrecordid>eNp1kU1uFDEQhVsIREJgwQWQJTZBSk9st90_y1EUyEiRYAFsrZp2tcbBbQ-2O0Oz4ghcg2txEjyZABISroWtqk_PVfWK4jmjC5bP-QZwwaocD4pjVtWy5JLVD_dvycqWs_qoeBLjDaWs4rR-XBzxphOVpPy4-PHOWJ9IAKf9aL6iPiPOu5_fvhs3YDA-mDSfkT74GHPS32IgKRiwxA_Eux5zcof4yc7kNi5I2gREksyI8W8hYO_HtXHgEhmgTz6Qj6vVimyD325mC19MJMYR0JNNkexM2pCI-SMkea4xM8YaIMunxaMBbMRn9_dJ8eH15fuLq_L67ZvVxfK67Ku2ZaUUkmrUuhYtp2tNZQvQs4bztWAopKiZ1k3NW9FU0HGkVTeA6BCg4YNsAKqT4vSgm_v7PGFMajSxR2vBoZ-iYq3kdc3zKjP68h_0xk_B5e4U6zgVLWu7PfXqQN1tMeCgtsGMEGbFqNr7p_Kc6s6_zL64V5zWI-o_5G_DMnB-AHbG4vx_JXW1vDxI_gImN6pI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920481892</pqid></control><display><type>article</type><title>Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Ragni, M. V. ; Yabes, J. G. ; Fogarty, P. F. ; Josephson, N. C. ; Kessler, C. M. ; Neff, A. T. ; Raffini, L. ; Brummel‐Ziedins, K. ; Moore, C. G.</creator><creatorcontrib>Ragni, M. V. ; Yabes, J. G. ; Fogarty, P. F. ; Josephson, N. C. ; Kessler, C. M. ; Neff, A. T. ; Raffini, L. ; Brummel‐Ziedins, K. ; Moore, C. G.</creatorcontrib><identifier>ISSN: 1351-8216</identifier><identifier>EISSN: 1365-2516</identifier><identifier>DOI: 10.1111/hae.13131</identifier><identifier>PMID: 27943502</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Coagulation factors ; Cross-Over Studies ; Factor VIII - therapeutic use ; Factor VIII deficiency ; Hemophilia ; Hemophilia A - drug therapy ; Humans ; Male ; Pilot Projects ; Prophylaxis</subject><ispartof>Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.e43-e46</ispartof><rights>2016 John Wiley & Sons Ltd</rights><rights>2017 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3881-5450dedd64820bd058aac1722b41e45461dd7628473a92e039fa49eaa72f57aa3</citedby><cites>FETCH-LOGICAL-c3881-5450dedd64820bd058aac1722b41e45461dd7628473a92e039fa49eaa72f57aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhae.13131$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhae.13131$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27943502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ragni, M. V.</creatorcontrib><creatorcontrib>Yabes, J. G.</creatorcontrib><creatorcontrib>Fogarty, P. F.</creatorcontrib><creatorcontrib>Josephson, N. C.</creatorcontrib><creatorcontrib>Kessler, C. M.</creatorcontrib><creatorcontrib>Neff, A. T.</creatorcontrib><creatorcontrib>Raffini, L.</creatorcontrib><creatorcontrib>Brummel‐Ziedins, K.</creatorcontrib><creatorcontrib>Moore, C. G.</creatorcontrib><title>Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A</title><title>Haemophilia : the official journal of the World Federation of Hemophilia</title><addtitle>Haemophilia</addtitle><subject>Coagulation factors</subject><subject>Cross-Over Studies</subject><subject>Factor VIII - therapeutic use</subject><subject>Factor VIII deficiency</subject><subject>Hemophilia</subject><subject>Hemophilia A - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Pilot Projects</subject><subject>Prophylaxis</subject><issn>1351-8216</issn><issn>1365-2516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1uFDEQhVsIREJgwQWQJTZBSk9st90_y1EUyEiRYAFsrZp2tcbBbQ-2O0Oz4ghcg2txEjyZABISroWtqk_PVfWK4jmjC5bP-QZwwaocD4pjVtWy5JLVD_dvycqWs_qoeBLjDaWs4rR-XBzxphOVpPy4-PHOWJ9IAKf9aL6iPiPOu5_fvhs3YDA-mDSfkT74GHPS32IgKRiwxA_Eux5zcof4yc7kNi5I2gREksyI8W8hYO_HtXHgEhmgTz6Qj6vVimyD325mC19MJMYR0JNNkexM2pCI-SMkea4xM8YaIMunxaMBbMRn9_dJ8eH15fuLq_L67ZvVxfK67Ku2ZaUUkmrUuhYtp2tNZQvQs4bztWAopKiZ1k3NW9FU0HGkVTeA6BCg4YNsAKqT4vSgm_v7PGFMajSxR2vBoZ-iYq3kdc3zKjP68h_0xk_B5e4U6zgVLWu7PfXqQN1tMeCgtsGMEGbFqNr7p_Kc6s6_zL64V5zWI-o_5G_DMnB-AHbG4vx_JXW1vDxI_gImN6pI</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Ragni, M. V.</creator><creator>Yabes, J. G.</creator><creator>Fogarty, P. F.</creator><creator>Josephson, N. C.</creator><creator>Kessler, C. M.</creator><creator>Neff, A. T.</creator><creator>Raffini, L.</creator><creator>Brummel‐Ziedins, K.</creator><creator>Moore, C. G.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A</title><author>Ragni, M. V. ; Yabes, J. G. ; Fogarty, P. F. ; Josephson, N. C. ; Kessler, C. M. ; Neff, A. T. ; Raffini, L. ; Brummel‐Ziedins, K. ; Moore, C. G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3881-5450dedd64820bd058aac1722b41e45461dd7628473a92e039fa49eaa72f57aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Coagulation factors</topic><topic>Cross-Over Studies</topic><topic>Factor VIII - therapeutic use</topic><topic>Factor VIII deficiency</topic><topic>Hemophilia</topic><topic>Hemophilia A - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Pilot Projects</topic><topic>Prophylaxis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ragni, M. V.</creatorcontrib><creatorcontrib>Yabes, J. G.</creatorcontrib><creatorcontrib>Fogarty, P. F.</creatorcontrib><creatorcontrib>Josephson, N. C.</creatorcontrib><creatorcontrib>Kessler, C. M.</creatorcontrib><creatorcontrib>Neff, A. T.</creatorcontrib><creatorcontrib>Raffini, L.</creatorcontrib><creatorcontrib>Brummel‐Ziedins, K.</creatorcontrib><creatorcontrib>Moore, C. G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ragni, M. V.</au><au>Yabes, J. G.</au><au>Fogarty, P. F.</au><au>Josephson, N. C.</au><au>Kessler, C. M.</au><au>Neff, A. T.</au><au>Raffini, L.</au><au>Brummel‐Ziedins, K.</au><au>Moore, C. G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A</atitle><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle><addtitle>Haemophilia</addtitle><date>2017-01</date><risdate>2017</risdate><volume>23</volume><issue>1</issue><spage>e43</spage><epage>e46</epage><pages>e43-e46</pages><issn>1351-8216</issn><eissn>1365-2516</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27943502</pmid><doi>10.1111/hae.13131</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1351-8216 |
| ispartof | Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.e43-e46 |
| issn | 1351-8216 1365-2516 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1852662132 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Coagulation factors Cross-Over Studies Factor VIII - therapeutic use Factor VIII deficiency Hemophilia Hemophilia A - drug therapy Humans Male Pilot Projects Prophylaxis |
| title | Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A16%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pilot%20randomized,%20non%E2%80%90inferiority,%20cross%E2%80%90over%20trial%20of%20once%E2%80%90weekly%20vs.%20three%20times%E2%80%90weekly%20recombinant%20factor%20VIII%20prophylaxis%20in%20adults%20with%20severe%20haemophilia%20A&rft.jtitle=Haemophilia%20:%20the%20official%20journal%20of%20the%20World%20Federation%20of%20Hemophilia&rft.au=Ragni,%20M.%20V.&rft.date=2017-01&rft.volume=23&rft.issue=1&rft.spage=e43&rft.epage=e46&rft.pages=e43-e46&rft.issn=1351-8216&rft.eissn=1365-2516&rft_id=info:doi/10.1111/hae.13131&rft_dat=%3Cproquest_cross%3E1852662132%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1920481892&rft_id=info:pmid/27943502&rfr_iscdi=true |